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Intensive carea b s t r a c t
Objectives: We assessed the effect of a skin-protective terpolymer barrier film around the catheter inser-
tion site on frequency of dressing disruptions and skin integrity issues (hyperaemia, skin irritation, resi-
dues of adhesives and moisture under the dressing). Secondary outcomes included colonisation of the
central venous catheter (CVC) and rates of central line-associated bloodstream infection.
Research methodology: A monocentric, open-label, randomised controlled trial was performed comparing
a control group receiving standard transparent catheter dressings without the skin-protecting barrier
film and an intervention group receiving a transparent chlorhexidine-impregnated dressing with use
of the skin-protective acrylic terpolymer barrier film (3MTM CavilonTM No - Sting Barrier Film, 3 M
Health Care, St. Paul, MN, USA).
Results: Sixty patients were enrolled and randomised in the study accounting for 60 central venous cathe-
ters and a total of 533 catheter days. Dressing disruptions occurred more frequently and at sooner time
point in the control group. Skin integrity issues were significantly less observed in the intervention group.
No differences in CVC colonisation or central line-associated bloodstream infection were observed.
Conclusions: The application of a barrier film creating a skin-protective polymer layer beneath transparent
catheter dressings is associatedwith less dressing disruptions and skin integrity issueswithout altering the
riskof infectious complications if used in combinationwith a chlorhexidine-impregnated catheter dressing.
 2017 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
18 A.I. Pivkina et al. / Intensive & Critical Care Nursing 46 (2018) 17–23Introduction patient was unable to do so prior to study enrollment. In the latterBloodstream infections represent an important source of infec-
tious morbidity in critically ill patients as they rank third among all
nosocomial infections (Agbaht et al., 2007; Blot et al., 2009;
Vincent et al., 2009; Tabah et al., 2012; Dimopoulos et al., 2013).
About one third of nosocomial bloodstream infections are related
to the insertion of intravascular catheters, mostly central line-
associated bloodstream infection (CLABSI)(Safdar et al., 2002;
Blot et al., 2003). Pooled estimates of mean occurrence rates of
CLABSI are 4.4 CLABSI per 100 devices inserted (95% confidence
interval [CI] 4.1-4.9) and 2.7 CLABSI per 1000 catheter days (95%
CI 2.6–2.9)(Maki et al., 2006). In addition, CLABSI carry a substan-
tial economic burden through an added length of hospitalisation
and excess hospital costs (Blot et al., 2005; Warren et al., 2006;
Higuera et al., 2007; Schwebel et al., 2012). As a consequence a
variety of measures to prevent CLABSI are advocated. These include
educational initiatives and use of care bundles or checklists to opti-
mise adherence with local recommendations, optimal catheter
insertion site selection, maximal sterile barriers during catheter
insertion, adequate disinfection of the insertion site and use of
chlorhexidine gluconate (CHG)-impregnated washcloths for daily
bathing (Hu et al., 2004; Labeau et al., 2008, 2009; Blot et al.,
2014a; Afonso et al., 2016; Arvaniti et al., 2016; Labeau et al.,
2016; Mimoz et al., 2016; Arvaniti 2017). Recently, the use of
CHG-impregnated dressings have demonstrated to significantly
reduce the risk of catheter infections (Timsit et al., 2012b).
Notwithstanding this innovative dressing, accidental dressing dis-
ruptions remain a particular risk factor for CLABSI (Timsit et al.,
2012a). Timsit and colleagues demonstrated that the risk for
CLABSI increased exponentially with the number of dressing dis-
ruptions: a hazard ratio (HR) of 1.2 (95% confidence interval [CI]
0.5–7.5) for a first disruption, a HR 3.3 (95% CI 1.2–9.0) for a second
disruption, and a 12.5 HR (95% CI 4.0–39.6) for a third dressing dis-
ruption. Therefore, dressings are designed to have an adequate
adhesive potential. However, this includes a potential risk of skin
breakdown that, on its turn, is a risk factor for CLABSI as well
because skin lesions contain a substantial number of potentially
pathogenic microorganisms. In order to avoid adhesives-related
skin breakdown a skin product has been developed creating a poly-
mer protective film. This film-forming liquid acrylate proved valu-
able to protect integrity of the peri-wound skin in chronic ulcers
(Schuren et al., 2005). To the best of our knowledge however, this
barrier film has never been used to protect the skin from adhesive
catheter dressings. In addition, it is uncertain to which extent the
use of such a barrier film affects the adhesive potential of the
catheter dressings. Furthermore, it is uncertain whether the appli-
cation of this barrier film facilitates CVC colonisation.
The objective of this study is to compare the standard use of
transparent dressings with transparent CHG-impregnated catheter
dressings with use of a skin-protective barrier film. Primary out-
comes were skin integrity and risk of dressing disruption. Second-
ary outcomes were rates of central venous catheter (CVC)
colonisation rates and CLABSI rates.
Methods
Setting
The study was executed during a five months period (August to
December 2014) in a specialised 12-bed intensive care unit (ICU)
for patients with infectious diseases or septic complications at
the Pirogov National Medical Surgical Center, Moscow. The local
ethics committee approved the study and informed consent was
required either from the patient or a legal representative if thecase, the patient was informed at a later stage and asked if he/she
concurred with the using the data for research purposes. The study
data are reported according to the Consolidated Standards of
Reporting Trials (CONSORT) statement.
Study design
A monocentric, open-label, randomized, controlled trial was
conducted to compare standard transparent dressings with trans-
parent CHG-impregnated catheter dressings (3 M Tegaderm CHGTM,
3 M Health Care, St. Paul, MN, USA). In addition, in the CHG-
dressing group the patients’ skin was treated with a liquid film-
forming acrylate (CavilonTM ‘‘No Sting Barrier Film”, 3 M Health
Care, St. Paul, MN, USA). The barrier film was applied on the skin
area immediately around the CVC insertion site. As such the study
resulted in a control group of patients with standard transparent
polyurethane CVC dressings and an intervention group with
CHG-impregnated transparent polyurethane CVC dressings with
use of the skin protective ointment. Patients were randomised fol-
lowing a random number generator.
Patient selection and follow-up
Besides informed consent, patients were eligible for study
inclusion when they were adult (16 years of age), had a clinical
indication for central venous catheterisation and an anticipated
length of catheter indwelling time of seven days. Exclusion criteria
included known allergy to chlorhexidine or dressing adhesives.
Patients were randomised to the control or the intervention group
before CVC insertion and follow-up of the patients lasted until CVC
removal. Patients could only be included once in the trial.
Outcomes
Primary outcomes were average dressing dwell time, number of
dressing disruptions and skin integrity. Skin integrity was judged
upon the following observations: (i) hyperaemia of the insertion
site, (ii) presence of skin irritations under the dressing, (iii) resi-
dues of adhesives on the skin and (iv) moisture under the dressing.
In dressing disruptions we considered either partial or full dressing
disruptions. Partial dressing disruption is defined as loosening of
the dressing without revealing the CVC insertion site, while full
dressing disruption is defined as loosening of the dressing leaving
the CVC insertion site uncovered.
Secondary outcomes included observations associated with
either inflammation or infection, i.e. presence of discharge from
the insertion site, CVC colonisation rates and CLABSI rates. After
removal the CVCs the catheter tips were evaluated for colonisation
by semiquantitative (roll-plate) culture (Maki et al., 1977). Hereby,
catheter colonisation was defined as a microbial growth of >15 col-
ony forming units (Mermel et al., 2009). As we evaluated the effi-
cacy of dressings, only the external surface of the catheter was
evaluated for microbial colonisation.
Patient characteristics
Data were collected in order to compare patient characteristics
between the two groups. These included demographics, concomi-
tantmedication, underlying conditions and aspects reflecting sever-
ity of acute illness. For the latter we reported the acute physiology
and chronic health evaluation (APACHE) II score and the sequential
organ failure assessment (SOFA) score (Knaus et al., 1985; Vincent
et al., 1996). Furthermore, the need for organ support either at the
time of study enrollment or during the complete study course was
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replacement therapy and vasopressors or inotropes.
Standard care
Standard catheter care included alcohol-based antiseptic (0.5%
chlorhexidine in 70% ethanol) for skin preparation before CVC
insertion, maximal sterile barriers including broad coverage of
the patients with sterile drapes, and use of sterile gowns and
gloves of the operator, mask and hat. After the insertion procedure,
the CVC was covered with either the standard transparent dressing
or the CHG-dressing according to the result of the randomisation
process. Catheter dressings were changed every seven days, or in
case of full dressing disruption or if moisture was present under
the dressing. Dressings were not changed in case of partial dressing
disruption provided the coverage of the insertion site.
Statistics
Descriptive variables are reported as n (%) or mean (standard
deviation) and median (interquartile range). Comparisons between
the study groups are executed with the Mann Whitney U test or
Fisher Exact test as appropriate. Colonisation and CLABSI rates
are expressed per 1000 CVC days. The Kaplan-Meier method with
a log-rank test was used to compare survival curves of both treat-
ment groups describing time until first dressing disruption. Statis-
tical significance is defined as p < 0.05.Fig. 1. Study floResults
Patient population
Fig. 1 describes the study flow diagram. Sixty patients were
enrolled in the study accounting for 60 CVCs and a total of 533
CVC days. No patients were excluded during the study and no
patient was lost to follow up. Characteristics of patients with stan-
dard and CHG-dressings are shown in Table 1. No important differ-
ences were observed between the two groups in gender, age, CVC
insertion site and dwell time, use of concomitant therapy, underly-
ing conditions and severity of disease as assessed by organ failure
and the need for organ support. All CVCs used were triple-lumen
catheters. Reasons for CVC removal were not different between
the groups and included no further need for a CVC (n = 28), clini-
cally suspected CLABSI (n = 19), mortality (n = 7), and planned
CVC change because of the need to initiate renal replacement ther-
apy (n = 5).Primary outcomes
Outcomes are reported in Table 2. Dressing dwell time was sig-
nificantly higher in the intervention group. Main reasons for dress-
ing changes included full dressing disruptions and moisture
beneath the dressing, which were more commonly observed in
the control group. Fig. 2 describes the Kaplan-Meier survival curves
comparing the time until the first dressing disruption. Dressingw diagram.
Table 1
Characteristics of study groups.
Feature Control group, Standard transparent dressing
without skin-protective barrier film (n = 30)
Intervention group, Transparent CHG-dressing
with skin-protective barrier film (n = 30)
p
Demographics
Male gender 14 (46.7) 12 (40.0) 0.795
Age, years 64 (56–73) 65.5 (56–69) 0.708
Length of hospital stay before enrollment, days 6.0 (1.25–10.5) 3.5 (2–6.75) 0.406
Catheter insertion site
Subclavian vein 16 (53.3) 17 (56.7) >0.999
Internal jugular vein 14 (46.7) 13 (43.3) >0.999
Catheter dwell time, days 8.0 (4.0–10.0) 9.5 (7.0–12.0) 0.108
Concomitant therapy
Antibiotic therapy 16 (53.3) 17 (56.7) 0.999
Glucocorticosteroid therapy 1 (3.3) 0 >0.999
Chemotherapy 1 (3.3) 0 >0.999
Parenteral nutrition,
At time of enrollment 5 (16.7) 1 (3.3) 0.195
During study course 6 (20.0) 4 (13.3) 0.731
Underlying conditions
Diabetes mellitus 1 (3.3) 2 (6.7) >0.999
Chronic obstructive pulmonary disease 1 (3.3) 4 (13.3) 0.202
Hypothyroidism 0 3 (10.0) 0.237
Severity of acute illness
Sepsis at time of enrollment 5 (16.7) 3 (10.0) 0.480
APACHE II score 17.5 (14–23) 16 (14–23) 0.904
SOFA score 3 (2–5) 4 (3–7) 0.182
Need for organ support at study enrollment
Mechanical ventilation 15 (50.0) 22 (73.3) 0.110
Renal replacement therapy 2 (6.7) 5 (16.7) 0.424
Vasopressors/inotropes 6 (20.0) 9 (30.0) 0.552
Mechanical ventilation 15 (50.0) 24 (80.0) 0.029
Renal replacement therapy 4 (13.3) 7 (23.3) 0.506
Vasopressors/inotropics 7 (23.3) 12 (40.0) 0.267
Data is reported as median (interquartile range) for continuous variables and n (%) for discrete variables. CHG, chlorhexidine gluconate impregnated; APACHE, acute
physiology ad chronic health evaluation; SOFA, sequential organ failure assessment.
Table 2
Study outcomes in patients with standard transparent dressings vs. transparent CHG-impregnated dressings with the use of a lotion creating a skin-protective polymer film.
Control group, Standard transparent dressing
without skin-protective barrier film (n = 30)
Intervention group, Transparent CHG-dressing,
with skin-protective barrier film (n = 30)
p
Primary outcomes
Dressing dwell time, days 2.5 (1.0–3.0) 7.0 (6.0–7.0) <0.001
Dressing disruptions
Partial 4 (13.3) 7 (23.3) 0.506
Full 17 (56.7) 2 (6.7) <0.001
Skin integrity
Hyperaemia of the insertion site 4 (13.3) 1 (3.3) 0.353
Presence of skin irritations 1 (3.3) 0 >0.999
Residues of adhesive on skin 0 0 >0.999
Moisture under the dressing 6 (20) 0 0.009
All skin integrity issues 11 (36.7) 1 (3.3) 0.001
Secondary outcomes
Presence of discharge from the insertion site 2 (6.7) 0 0.492
CVC colonisation 9 (30.0) 11 (36.7) 0.785
CLABSI 5 (16.7) 2 (6.7) 0.424
Data is reported as median (interquartile range) for continuous variables and n (%) for discrete variables. CHG, chlorhexidine gluconate impregnated; CVC, central venous
catheter; CLABSI, central line-associated bloodstream infection.
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the control group (Log rank test: p < 0.001).
Overall skin integrity issues were more commonly observed in
the control group (p = 0.001). This significant difference could
mainly be attributed to the presence of moisture under the dress-
ing and hyperaemia at the insertion site.
Secondary outcomes
Discharge from the CVC insertion site was only observed in two
cases in the control group. All CVCs were cultured. Rates of CVC
colonisation or infection per patient numbers are reported inTable 2. In addition, we calculated these infectious indices per
1000 catheter days. Rates of CVC colonisation were not different
(37.9/1000 CVC days in the intervention group vs. 37.0/1000 CVC
days in the control arm [relative risk 1.22, 95% confidence interval
0.59–2.5]) as were CLABSI rates (6.9/1000 vs. 20.6/1000 CVC days
[relative risk 0.4, 95% confidence interval, 0.08–1.9]).
Discussion
In this randomised controlled trial we assessed the value of a
barrier film creating a polymer skin-protective layer around the
catheter insertion site on dressing disruptions and skin integrity.
Fig. 2. Survival curves describing time till first dressing disruption.The solid line represents the control group (standard transparent dressing) and the dashed line represents
the intervention group (transparent chlorhexidine-impregnated catheter dressing with use of a product creating a skin-protective polymer film). Log rank test: p < 0.001
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Dressing disruptions as well as skin integrity issues occurred more
frequently in the control group.
This finding is important as dressing disruptions as well as skin
breakdown in the immediate surrounding of the insertion site are
potential risk factors for CVC colonisation and subsequent infection
(Timsit et al., 2012a). While Cavilon

skin barrier film has been
proved successful in maintaining integrity of the peri-wound skin,
as far as we know it has not been evaluated beneath catheter
dressings. As such it remained uncertain what the effect of this
barrier film would be on likelihood of dressing disruptions and
infectious complications. An absolute decrease in CLABSI rates
was observed, but the study lacked power to demonstrate statisti-
cal significance. This non-significant reduction in CLABSI risk can
be attributed to the fact that a CHG-dressing was used in the inter-
vention group. This dressing significantly reduced CLABSI risk in a
large multicenter randomised controlled trial and these results
were later on confirmed in a meta-analysis including nine ran-
domised studies (Timsit et al., 2012b; Safdar et al., 2014). While
a favorable effect of the barrier film in terms of skin integrity could
be expected based on previous studies, and albeit that skin integ-
rity has a negative effect on the risk of CVC colonisation/infection,
it remained uncertain whether the use of this barrier film in the
immediate zone of the insertion site could have increased the risk
of infectious complications. Based on our observations we can state
that the use of a product creating a polymer skin-protective film
does not negatively influence the risk of catheter infection, at least
not when used in combination with a CHG-impregnated catheter
dressing.
We must recognise that CLABSI rates in our study were high
with rates of about 7/1000 and 20/1000 CVC days in the interven-
tion group and the control group, respectively. In a systematic
review of quality improvement initiatives to reduce the risk of
CLABSI, six studies were identified with a baseline CLABSI rate
>15/1000 CVC days (Blot et al., 2014a). Our study must be situated
within this range. The high CLABSI rate might be partially
explained by the specific patient population as the study was con-ducted in an ICU specialised to treat patients suffering from infec-
tious complications. In addition, the cohort was older with about a
quarter of patients aged over 70 years and high occurrence rates of
organ failure. Older age as well as multiple organ failure are well-
recognized risk factors for infectious complications in general (Blot
and Vandewoude 2004; Vandewoude et al., 2004; Reynvoet et al.,
2009; Reunes et al., 2011; Blot et al., 2014b; Sousa et al., 2017).
Furthermore, the standard nurse-to-patient ratio is 1:3 while nurs-
ing shifts last for 24 hours. Especially the latter contributes to an
excessive workload which is associated with sub-optimal compli-
ance with recommendations in infection prevention and indicated
as a main barrier to comply with local protocols in ICUs (Rello
et al., 2002; De Wandel et al., 2010; Lambert et al., 2013;
Valencia et al., 2016; Battistella et al., 2017; De Wandel 2017;
Piras et al., 2017; Sadule-Rios and Aguilera 2017; Velasquez
Reyes et al., 2017).Limitations
This study has limitations. As already mentioned the sample
size was not powered for detecting differences in CLABSI rates.
Moreover, the fact that two different dressing were used makes
an evaluation of infectious complications at the catheter site diffi-
cult. Because two interventions were combined in the intervention
group it is not possible to evaluate the value of the acrylic terpoly-
mer barrier film in combination with a standard polyurethane
dressing. As such it is, at least theoretically, possible that the appli-
cation of the barrier film increases the risk of CVC colonisation, but
that in this study this (unproven) deleterious effect has been
erased by the use of a CHG-impregnated dressing in the interven-
tion group. In the same line, we cannot rule out that the chlorhex-
idine gel pad absorbed small proportions of the barrier film, but
this unlikely as the substance is compatible with CHG. This might
have influenced the properties of the dressing and as such the out-
comes. However, the skin-protective barrier film was carefully
applied in the zone around the gel pad where the adhesive part
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dressing disruption starts when these outer parts of the dressing
loose contact with the skin, we believe that the eventual influence
of combining the barrier film with the CHG-dressing only margin-
ally might have impacted to study outcome. Finally, subsequent
dressing disruptions were not recorded. However, the fact that
only the first dressing disruption was considered is unlikely to
change the final conclusion, i.e. the barrier film protects against
accidental dressing disruptions.
Conclusion
The use of a skin product creating a polymer protective film
beneath transparent dressings results in longer dressing dwell
times and less skin breakdown. The application of the skin product
does not alter the risk of CVC colonisation or CLABSI, at least not
when used combined with a CHG-impregnated dressing.
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